Abstract
Stimulation of Natural Killer (NK) cells with cytokines, target cell interaction, or antibody mediated activation of receptors on the NK cell surface enables the dissection of specific signaling intermediates in different activation pathways. NK cell activation status is commonly measured by production of interferon gamma (IFNγ) and expression of the degranulation marker LAMP-1 (CD107a). Cytotoxic potency can also be assessed by the production of perforin, granzymes, and tumor necrosis factor alpha (TNFα). NK cell receptor mediated activation by antibodies requires crosslinking of the receptor-specific antibodies; thus, in vitro activation assays are performed by binding antibodies to cell culture plates. All parameters can be measured by flow cytometry.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Gregoire C, Chasson L, Luci C et al (2007) The trafficking of natural killer cells. Immunol Rev 220:169–182
Ortaldo JR, Wiltrout RH, Reynolds CW (2014) Natural killer activity: early days, advances, and seminal observations. Crit Rev Oncog 19:1–13. https://doi.org/10.1615/critrevoncog.2014011125
Rosenberg EB, Herberman RB, Levine PH et al (1972) Lymphocyte cytotoxicity reactions to leukemia-associated antigens in identical twins. Int J Cancer 9:648–658
Ljunggren HG, Karre K (1985) Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J Exp Med 162:1745–1759
Rajasekaran K, Kumar P, Schuldt KM et al (2013) Signaling by Fyn-ADAP via the Carma1-Bcl-10-MAP3K7 signalosome exclusively regulates inflammatory cytokine production in NK cells. Nat Immunol 14:1127–1136
Reefman E, Kay JG, Wood SM et al (2010) Cytokine secretion is distinct from secretion of cytotoxic granules in NK cells. J Immunol 184:4852–4862
Aktas E, Kucuksezer UC, Bilgic S et al (2009) Relationship between CD107a expression and cytotoxic activity. Cell Immunol 254:149–154
Alter G, Malenfant JM, Altfeld M (2004) CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294:15–22
Vahlne G, Becker S, Brodin P et al (2008) IFN-gamma production and degranulation are differentially regulated in response to stimulation in murine natural killer cells. Scand J Immunol 67:1–11
Delconte RB, Kolesnik TB, Dagley LF et al (2016) CIS is a potent checkpoint in NK cell-mediated tumor immunity. Nat Immunol 17:816–824
Bryceson YT, March ME, Ljunggren HG et al (2006) Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107:159–166
Sun JC, Beilke JN, Bezman NA et al (2011) Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection. J Exp Med 208:357–368
Meza Guzman LG, Keating N, Nicholson SE (2020) Natural killer cells: tumor surveillance and signaling. Cancers 12:952
Hayakawa Y, Kelly JM, Westwood JA et al (2002) Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin. J Immunol 169:5377–5381
Acknowledgments
This work was in part supported through a grant from the National Health and Medical Research Council of Australia (1124784) and through Victorian State Government Operational Infrastructure Support and the Australian Government National Health and Medical Research Council Independent Research Institute Infrastructure Support scheme.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Meza Guzman, L.G., Nicholson, S.E. (2022). Determining Activation Status of Natural Killer Cells Following Stimulation via Cytokines and Surface Receptors. In: Shimasaki, N. (eds) Natural Killer (NK) Cells. Methods in Molecular Biology, vol 2463. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2160-8_13
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2160-8_13
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2159-2
Online ISBN: 978-1-0716-2160-8
eBook Packages: Springer Protocols